Related references
Note: Only part of the references are listed.LCAT protects against Lipoprotein-X formation in a murine model of drug-induced intrahepatic cholestasis
Marcelo J. A. Amar et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2020)
Lipoprotein-X fifty years after its original discovery
R. Fellin et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2019)
Plasma lipoprotein-X quantification on filipin-stained gels: monitoring recombinant LCAT treatment ex vivo
Lita A. Freeman et al.
JOURNAL OF LIPID RESEARCH (2019)
Controversy over the atherogenicity of lipoprotein-X
Takashi Miida et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2019)
Advances in capillary electrophoresis for the life sciences
Javier Sastre Torano et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2019)
LCAT Enzyme Replacement Therapy Reduces LpX and Improves Kidney Function in a Mouse Model of Familial LCAT Deficiency
Boris L. Vaisman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Hypercholesterolemia Due to Lipoprotein X: Case Report and Thematic Review
Laura Kattah et al.
CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES (2019)
Lipoprotein-X in cholestatic patients causes xanthomas and promotes foam cell formation in human macrophages
Luka Suzuki et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2017)
Lipid profiling of lipoprotein X: Implications for dyslipidemia in cholestasis
Susanne Heimerl et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2016)
Cholesterol metabolism in cholestatic liver disease and liver transplantation: From molecular mechanisms to clinical implications
Katriina Nemes et al.
WORLD JOURNAL OF HEPATOLOGY (2016)
Severe hypercholesterolemia mediated by lipoprotein X in a patient with cholestasis
Dineo V. Phatlhane et al.
ANNALS OF HEPATOLOGY (2015)
Differences in reaction specificity toward lipoprotein X and abnormal LDL among 6 homogeneous assays for LDL-cholesterol
Kazumi Matsushima et al.
CLINICA CHIMICA ACTA (2015)
Management of lipoprotein X and its complications in a patient with primary sclerosing cholangitis
Eric J. Brandt et al.
CLINICAL LIPIDOLOGY (2015)
Extreme hypercholesterolemia presenting with pseudohyponatremia - a case report and review of the literature
Iram Hussain et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2015)
Multiple lipoprotein and electrolyte laboratory artifacts caused by lipoprotein X in obstructive biliary cholestasis secondary to pancreatic cancer
Tharsan Sivakumar et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2011)
Serum LDL- and HDL-cholesterol determined by ultracentrifugation and HPLC
Jun Dong et al.
JOURNAL OF LIPID RESEARCH (2011)
Jones oxidation and high performance liquid chromatographic analysis of cholesterol in biological samples
Jun Dong et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
Role of plasma and liver cholesterol- and lipoprotein-metabolism determinants in LpX formation in the mouse
Ignacio Bravo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2007)
Interference in a homogeneous assay for low-density lipoprotein cholesterol by lipoprotein X
Ileana Herzum et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2007)
Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation
PY Chang et al.
JOURNAL OF LIPID RESEARCH (2004)
Share Paper
